These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2211127)

  • 1. Cohort study of thyroid disease near the Nevada Test Site: a preliminary report.
    Rallison ML; Lotz TM; Bishop M; Divine W; Haywood K; Lyon JL; Stevens W
    Health Phys; 1990 Nov; 59(5):739-46. PubMed ID: 2211127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a method to estimate thyroid dose from fallout radioiodine in a cohort study.
    Simon SL; Lloyd RD; Till JE; Hawthorne HA; Gren DC; Rallison ML; Stevens W
    Health Phys; 1990 Nov; 59(5):669-91. PubMed ID: 2211123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.
    Kerber RA; Till JE; Simon SL; Lyon JL; Thomas DC; Preston-Martin S; Rallison ML; Lloyd RD; Stevens W
    JAMA; 1993 Nov; 270(17):2076-82. PubMed ID: 8411574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Utah Thyroid Cohort Study: analysis of the dosimetry results.
    Till JE; Simon SL; Kerber R; Lloyd RD; Stevens W; Thomas DC; Lyon JL; Preston-Martin S
    Health Phys; 1995 Apr; 68(4):472-83. PubMed ID: 7883559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data.
    Lyon JL; Alder SC; Stone MB; Scholl A; Reading JC; Holubkov R; Sheng X; White GL; Hegmann KT; Anspaugh L; Hoffman FO; Simon SL; Thomas B; Carroll R; Meikle AW
    Epidemiology; 2006 Nov; 17(6):604-14. PubMed ID: 17028502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
    Wachholz BW
    Health Phys; 1990 Nov; 59(5):511-4. PubMed ID: 2211110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimates of exposure rates and fallout arrival times near the Nevada Test Site.
    Thompson CB
    Health Phys; 1990 Nov; 59(5):555-63. PubMed ID: 2211115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual external exposures from Nevada Test Site fallout for Utah leukemia cases and controls.
    Lloyd RD; Gren DC; Simon SL; Wrenn ME; Hawthorne HA; Lotz TM; Stevens W; Till JE
    Health Phys; 1990 Nov; 59(5):723-37. PubMed ID: 2211126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid disease in children. A survey of subjects potentially exposed to fallout radiation.
    Rallison ML; Dobyns BM; Keating FR; Rall JE; Tyler FH
    Am J Med; 1974 Apr; 56(4):457-63. PubMed ID: 4818412
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural history of thyroid abnormalities: prevalence, incidence, and regression of thyroid diseases in adolescents and young adults.
    Rallison ML; Dobyns BM; Meikle AW; Bishop M; Lyon JL; Stevens W
    Am J Med; 1991 Oct; 91(4):363-70. PubMed ID: 1951380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests.
    Gilbert ES; Tarone R; Bouville A; Ron E
    J Natl Cancer Inst; 1998 Nov; 90(21):1654-60. PubMed ID: 9811315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimates of fallout in the continental U.S. from Nevada weapons testing based on gummed-film monitoring data.
    Beck HL; Helfer IK; Bouville A; Dreicer M
    Health Phys; 1990 Nov; 59(5):565-76. PubMed ID: 2211116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid cancer risk in the population around the Nevada Test Site.
    Zeighami EA; Morris MD
    Health Phys; 1986 Jan; 50(1):19-32. PubMed ID: 3943971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests.
    Hundahl SA
    CA Cancer J Clin; 1998; 48(5):285-98. PubMed ID: 9742895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meteorological modeling of arrival and deposition of fallout at intermediate distances downwind of the Nevada Test Site.
    Cederwall RT; Peterson KR
    Health Phys; 1990 Nov; 59(5):593-601. PubMed ID: 2211118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical estimates of external gamma exposure and collective external gamma exposure from testing at the Nevada Test Site. II. Test series after Hardtack II, 1958, and summary.
    Anspaugh LR; Ricker YE; Black SC; Grossman RF; Wheeler DL; Church BW; Quinn VE
    Health Phys; 1990 Nov; 59(5):525-32. PubMed ID: 2211112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models of radioiodine transport to populations within the continental U.S.
    Bouville A; Dreicer M; Beck HL; Hoecker WH; Wachholz BW
    Health Phys; 1990 Nov; 59(5):659-68. PubMed ID: 2145245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downwind.
    Caelleigh AS
    Acad Med; 1997 Nov; 72(11):940. PubMed ID: 9387814
    [No Abstract]   [Full Text] [Related]  

  • 19. Ground-based air-sampling measurements near the Nevada Test Site after atmospheric nuclear tests.
    Cederwall RT; Ricker YE; Cederwall PL; Homan DN; Anspaugh LR
    Health Phys; 1990 Nov; 59(5):533-40. PubMed ID: 2211113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer incidence in an area of radioactive fallout downwind from the Nevada Test Site.
    Johnson CJ
    JAMA; 1984 Jan; 251(2):230-6. PubMed ID: 6690781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.